Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Fundraising > $100 Million Naming Rights: Entitlement or Need?

Tags

  • drugs
  • would
  • biological
  • naming rights
  • business schools

  • Links

  • Secured Homeowner Loans - Low Cost Borrowings Without Hurdles
  • Internet Access in Sydney
  • The Power of Play - What Children Learn by Unstructured Play
  • Digg It - $100 Million Naming Rights: Entitlement or Need?

    Mile high expectations or just a fishing trip?

    In late November of 2006, the University of Colorado announced a $25 million gift from Denver philanthropist Phillip Anschutz. In appreciation of this donation, the Medical Campus in Aurora was re-named in Anschutz’s honor.

    The School of Medicine used
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    the announcement to trumpet the call for a naming rights donor, asking price $100 million. Interesting tactic in the grand scheme of fundraising efforts.

    An emerging trend in the non-profit sector is the super-charged escalation of ASK AMOUNTS for naming rights. This trend is directly linked to th
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    e surge in billion dollar fundraising campaigns currently underway at universities, colleges, environmental groups and others across the USA.

    I wonder aloud sometimes and ask the wind, “Who checks the moral barometer of non-profit entities?” Which organization is genuinely qualified to ask for a $
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    100 million gift in return for the perpetual naming rights to an intangible like a school of medicine?

    Is this about entitlement or need?

    Benchmarking Named Gifts to universities

    Last August Stanford University received a $105 million gift from the founder of Knight Industries and in turn named
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    the Knight Graduate School of Management. The dollar amount of $105 million by the way, made it the number one ranked named gift to a Business School, $5 million more than the gift made to the University of Michigan in December of 2004.

    Stanford is ranked # 7 Best National University – Doctoral le
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    vel by the U.S. News and World Report. The six schools ahead of Stanford include Princeton, Harvard, Yale, Cal Tech, Duke and MIT.

    Now add to that perspective, there are only two business schools that have received a nine figure gift. That’s it. Of the 67 named Business Schools, #21 ranked Carnegie
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    Mellon University, is next, having received a $55 million gift in 2004.

    For the record, there have been more naming gifts made to Business Schools than to Medicine, Law and Engineering combined. Capitalism helped to create wealth, some are giving back in a big way.

    Naming rights for non-profit or
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    ganizations take their benchmarks from these named Business Schools. Every now and then there is a gift outside the norm, made by someone who has financial capacity and a strong emotional attachment to the institution.

    UCLA - David Geffen School of Medicine ( 2002 ) $ 200 million

    University of
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    Miami - Miller School of Medicine ( 2004 ) $ 100 million

    Cornell University - Weill Medical College ( 1998 ) $ 100 million

    Northwestern University - Feinburg School of Medicine ( 2002 ) $ 75 million

    Stanford - Knight School of Management ( 2006 ) $ 105 million

    University of Michigan -
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    Ross School of Business ( 2004 ) $ 100 million

    Carnegie Mellon University -Tepper School of Business ( 2004 ) $ 55 million

    University of Texas, Austin - McCombs School of Business ( 2004 ) $ 50 million

    I pose the question once again. Are the naming rights dollar figures about need or a s
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ense of entitlement?

    To the universities and colleges, receiving a large naming gift is like winning the lottery. Truth be known, it’s better because unlike someone who claims a windfall from a random lottery ticket, there are no state or federal withholding taxes skimmed off the top. It’s more lik
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    e cashing in a tax-free prize from the Irish Sweepstakes.

    For any university to be so bold as to peg their naming rights for a designated asset at $100 million appears to be one of self-serving entitlement. Public universities in particular. We do because we can.

    Twenty years ago, philanthropy was
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    all about contributing to a favorite charity because of the emotional ties that made us a part of the organization.

    Contemporary fundraisers seem to be focused in on pushing for as much as you can every time they ask for a gift. Profiling of the would-be donors is skewed towards a what’s-in-it-for
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    -us background research according to wealth indicators. Many times the profiles are compiled without ever having a conversation with the individual, foundation, corporation or other possible benefactor.

    Maybe it’s the system that is bent. When senior fundraising staff look around and see the off th
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    e chart numbers being asked for naming rights at other schools they appear to be ready to announce in public, “me too.”

    Is that enough? Why don’t we question them or ask them to validate their numbers?

    Should they not have to back it up with some sort of track record of outstanding accomplishments
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    such as a highly touted academic curriculum, multiple Nobel Prize winning faculty on staff or evidence of breakthrough research by accomplished professors? How did they come up with a $100 million price tag anyway?

    Why are they not accountable to show deemed value in these naming rights? Should th
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    e donor community blindly accept any dollar amount that a university or college chooses to ask for its’ naming rights?

    And what kind of influence do these high minded tactics have on the rest of the non-profit organizations in that community? Not to mention the impact they have on donor’s choices t
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    o distribute the same amount of money to a wider group of deserving organizations.

    A month before I wrote this article there was an announcement from the corporate side of the fence. Citibank, the largest financial services company in the land and one of the largest in the world, announced two nami
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    ng rights deals on successive days.

    The first was a commercial sector naming rights agreement for $20 million for the baseball stadium where the New York Mets play. The second was a $ 34 million dollar deal to name the Wang Center for Performing Arts in Boston. Isn’t it interesting to see a bank pa
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    y almost double what it paid for naming rights in what most refer to as the media capital of the world?

    Are universities that chose these fundraising strategies more about benevolence and working towards the greater good or merely acting out repressed ambitions to be the wealthiest kid on the block


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/19736/diggit-100-Million-Naming-Rights-Entitlement-or-Need.html">$100 Million Naming Rights: Entitlement or Need?</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/19736/diggit-100-Million-Naming-Rights-Entitlement-or-Need.html]$100 Million Naming Rights: Entitlement or Need?[/url]

    Related Articles:

    EBay Selling Tips

    Retail's First Moment Of Truth - The Package

    Business Ownership: Start Young

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com